Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2026 13:00 ET | Source: IT Link

Groupe IT Link : 4,7 M€ de résultat opérationnel courant sur l’exercice 2025

Communiqué FinancierLe Kremlin-Bicêtre, le 26 mars 2026 En M€ S2 2024(1)S2 2025(1)VariationChiffre d’Affaires40,7440,27-1,1%EBITDA(2)4,053,27-19,3%% du Chiffre d’Affaires9,9%8,1% Résultat...
March 26, 2026 09:27 ET | Source: Can-Fite BioPharma Ltd.

Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient

RAMAT GAN, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs...
March 26, 2026 09:00 ET | Source: Interlink Electronics, Inc.

Interlink Electronics Reports Fourth Quarter 2025 Results

FREMONT, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Interlink Electronics, Inc. (Nasdaq: LINK) (“Interlink” or the “Company”), a global leader in sensor technology and printed electronic solutions,...
March 26, 2026 08:36 ET | Source: Formula Systems (1985) Ltd.

Formula Systems Reports Fourth Quarter and Full Year 2025 Financial Results

PRESS RELEASE 2025 Full-year revenues increased by 18.4% year over year, reaching $2.63 billion. Net income attributable to Formula shareholders reached $606.5 million following the completion of...
March 26, 2026 08:30 ET | Source: Alliance Creative Group, Inc.

Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report

CHICAGO, March 26, 2026 (GLOBE NEWSWIRE) -- via IBN -- Alliance Creative Group, Inc., (http://www.ACGX.us), a technology-driven holding company focused on AI-powered media, marketing, and digital...
March 26, 2026 08:30 ET | Source: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

– Closes Private Placement Financing of Up to $104.5 Million – Secures Orphan Drug Designations for QRX003 for Netherton Syndrome (NS) in the U.S. and Europe – Advances Proposed Expedited...
March 26, 2026 08:28 ET | Source: ParaZero Technologies Ltd.

ParaZero Reports 2025 Financial Results

KFAR SABA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for...
March 26, 2026 08:00 ET | Source: MeiraGTx

MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results

FDA granted Breakthrough Therapy Designation for AAV2-hAQP1 for the treatment of Grade 2 and Grade 3 late xerostomia caused by radiotherapy for cancers of the upper aerodigestive tractMeiraGTx to hold...
March 26, 2026 08:00 ET | Source: Servus Credit Union

Servus Credit Union Surpasses $10 Billion in Wealth Assets as Part of Strong Q1 Results

Servus Credit Union announced today its financial results for Q1 of fiscal 2026, reporting income before taxes and patronage of $110 million.
March 26, 2026 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...